Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Salim Group is a large Indonesian conglomerate controlled by the Salim family, with major interests in food, retail, agribusiness, automotive, banking, telecommunications, infrastructure, chemicals, property, and other industrial sectors. It is best known through major portfolio companies such as Indofood and other operating businesses across Southeast Asia. The group is an active operating and investment organization rather than a biotechnology, pharmaceutical, or healthcare company. While some third-party sources mention healthcare-related investments in certain contexts, Salim Group does not appear to be primarily a life sciences business and does not have a disclosed drug-development pipeline. For biotech and pharma diligence purposes, this entity should generally be classified as a non-health diversified conglomerate unless a specific healthcare subsidiary is intended instead.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Salim Group.